Saturday 17 October 2026
Export NDRA’s income statement to Excel — free account
ENDRA Life Sciences Inc.
NDRA Healthcare Diagnostics & Research
In the quarter to June 2026, EPS grew 107.0% and free cash flow grew 15.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
4.74
0.36
−7.06%
Follow NDRA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | 6 | — | — |
P/E ratio |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | — | 14.67 | 19.97 | 0.00 |
Altman Z-Score |
— | — | — | — | — | — | — | (5.26) | 6.49 | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | — | (8.73) | (2.68) | (124.25) |
P/FCF ratio |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | — | — | (2.76) | (12.59) | (11.95) |
P/B ratio |
— | — | — | — | — | — | — | 0.84 | 3.28 | 1.75 |
Price to Tangible BV |
— | — | — | — | — | — | — | 0.84 | 3.28 | 1.75 |
EV/Sales |
— | — | — | — | — | — | — | (3.41) | 13.51 | 0.00 |
EV/EBITDA |
— | — | — | — | — | — | — | 0.15 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | — | 0.16 | (3.55) | (3.19) |
EV/FCF |
— | — | — | — | — | — | — | 0.16 | (3.54) | (3.19) |
Quick Ratio |
1.02 | 5.34 | 3.14 | 2.87 | 6.13 | 7.32 | 2.98 | 6.64 | 6.61 | 0.10 |
Current Ratio |
1.29 | 5.67 | 3.36 | 4.71 | 7.83 | 8.32 | 3.15 | 7.13 | 6.93 | 0.14 |
Net Debt/EBITDA |
0.14 | 0.30 | 0.27 | 0.38 | 0.83 | 0.61 | 0.67 | 0.79 | 1.45 | (0.97) |
Debt/Assets |
0.00% | 0.00% | 0.42% | 0.31% | 1.25% | 4.72% | 9.85% | 0.00% | 0.00% | 193.56% |
Debt/Equity |
0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.06 | 0.15 | 0.00 | 0.00 | (1.06) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.16 |
Operating CF/Net income |
0.74 | 0.64 | 0.95 | 0.97 | 0.98 | 0.89 | 0.49 | 0.79 | 0.61 | 0.47 |
Capex/Depreciation |
(19.18) | (0.06) | (0.09) | (0.86) | (0.20) | (0.19) | (0.02) | (0.13) | (0.01) | 0.00 |
| (291.56%) | (280.02%) | (156.42%) | (146.53%) | (126.46%) | (203.20%) | (318.39%) | (170.02%) | (245.43%) | (126.68%) | |
| (169.21%) | (205.38%) | (125.53%) | (119.01%) | (104.92%) | (152.07%) | (243.43%) | (146.80%) | (162.58%) | (83.92%) | |
ROIC |
(240.50%) | 0.00% | (230.43%) | (350.85%) | (484.39%) | (2,021.57%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(2,708.05%) | (397.13%) | (448.82%) | (201.02%) | (106.28%) | (163.07%) | (373.00%) | (156.79%) | (101.92%) | 310.55% |
Average Days of Receivables |
— | — | — | — | — | — | — | 0.00 | 7.16 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 76,169.35% | 549.23% | 96.08% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 64,761.29% | 817.35% | 305.68% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | — | — | 1.14 | 0.29 | 0.55 |
Graham Number |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | — | (144.52%) | (50.45%) | (100.55%) |
Free Cash Flow Yield |
— | — | — | — | — | — | — | (148.62%) | (19.10%) | (14.06%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.00 | 3,516.00 | 0.00 |
Operating CF per Share |
(6.59) | (36.64) | (2,652.44) | (7,511.41) | (9,268.67) | (21,493.20) | (42,944.50) | (77,025.00) | (33,009.00) | 0.00 |
Capex per Share |
(3.83) | (0.06) | (6.86) | (119.18) | (37.50) | (150.60) | (218.00) | (1,000.00) | (79.00) | 0.00 |
Free Cash Flow per Share |
(10.42) | (36.70) | (2,659.31) | (7,630.59) | (9,306.17) | (21,643.80) | (43,162.50) | (78,025.00) | (33,088.00) | 0.00 |
Cash per Share |
0.97 | 15.99 | 787.19 | 2,875.94 | 7,884.58 | 14,454.60 | 30,871.00 | 64,714.00 | 56,019.00 | 0.00 |
Shareholders Equity per Share |
2.87 | 12.68 | 1,571.94 | 4,237.94 | 8,986.92 | 14,338.60 | 23,803.50 | 62,482.00 | 52,755.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.87 | 12.68 | 1,571.94 | 4,237.94 | 8,986.92 | 14,338.60 | 23,803.50 | 62,482.00 | 52,755.00 | 0.00 |
Free Cash Flow |
(8.20) | (7.41) | (9.57) | (12.97) | (11.17) | (10.82) | (8.63) | (7.80) | (3.31) | (1.32) |
Working Capital |
0.22 | 2.83 | 2.13 | 6.32 | 10.55 | 7.22 | 4.46 | 5.98 | 5.03 | (1.19) |
Capital Expenditures |
(3.02) | (0.01) | (0.02) | (0.20) | (0.04) | (0.08) | (0.04) | (0.10) | (0.01) | — |
Net Current Asset Value |
(0.63) | 1.54 | 1.94 | 5.95 | 10.00 | 6.61 | 4.12 | 5.98 | 5.03 | (1.19) |
EV/EBIT |
— | — | — | — | — | — | — | 0.14 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.13 | 0.02 | 0.00 |
Price to Operating Income |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
3.70 | 2.98 | 2.46 | 0.99 | 1.71 | 1.87 | 11.51 | 2.92 | 3.20 | 3.27 |
Cash ROIC |
(271.30%) | (128.04%) | (112.35%) | (107.01%) | (54.72%) | (73.07%) | (74.15%) | (61.34%) | (30.42%) | (653.88%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.39 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.49 | 2.04 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,791.63 | 672.44 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 404.92 | 62.05 |
Average Payables |
0.56 | 0.60 | 1.11 | 1.47 | 1.16 | 1.31 | 1.34 | 0.91 | 0.64 | 0.61 |
Average Inventory |
— | — | 2.63 | 1.96 | 0.94 | 0.35 | 0.09 | 0.13 | 0.12 | 0.12 |
Average Assets |
4.15 | 5.60 | 8.01 | 11.07 | 10.82 | 7.97 | 7.20 | 6.67 | 3.31 | 3.31 |
Average Common Equity |
2.41 | 4.11 | 6.43 | 8.99 | 8.98 | 5.97 | 5.50 | 5.76 | 2.19 | 2.19 |
Columns are period end dates